Here's What Key Metrics Tell Us About AdvanSix (ASIX) Q2 Earnings

Core Insights - AdvanSix reported revenue of $453.48 million for the quarter ended June 2024, reflecting a 6% increase year-over-year and surpassing the Zacks Consensus Estimate of$ 426.8 million by 6.25% [1] - The company's EPS was $1.55, up from$ 1.25 in the same quarter last year, exceeding the consensus EPS estimate of $1.20 by 29.17% [1] Revenue Breakdown - Sales from Nylon reached$ 103.22 million, exceeding the estimated $95.60 million, marking an 11% increase compared to the previous year [3] - Sales from Ammonium Sulfate totaled$ 139.67 million, surpassing the estimated $124.07 million, with a slight year-over-year increase of 0.5% [4] - Sales from Chemical Intermediates were$ 129.29 million, above the estimated $125.08 million, representing a 6.5% increase year-over-year [5] - Sales from Caprolactam amounted to$ 81.30 million, slightly below the estimated $82.05 million, but still showing an 8.9% increase compared to the previous year [6] Stock Performance - AdvanSix shares have returned +20.7% over the past month, contrasting with a -0.4% change in the Zacks S&P 500 composite [6] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [6]